Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Kwasi Adu‐Berchie"'
Autor:
Kwasi Adu-Berchie, Joshua M. Brockman, Yutong Liu, Tania W. To, David K. Y. Zhang, Alexander J. Najibi, Yoav Binenbaum, Alexander Stafford, Nikolaos Dimitrakakis, Miguel C. Sobral, Maxence O. Dellacherie, David J. Mooney
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Although adoptive T cell therapy provides the T cell pool needed for immediate tumor debulking, the infused T cells generally have a narrow repertoire for antigen recognition and limited ability for long-term protection. Here, we present a h
Externí odkaz:
https://doaj.org/article/c82858dc6c3249e0bed06dcad9fd4919
Autor:
David K. Y. Zhang, Kwasi Adu-Berchie, Siddharth Iyer, Yutong Liu, Nicoletta Cieri, Joshua M. Brockman, Donna Neuberg, Catherine J. Wu, David J. Mooney
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
‘Manufacturing CAR-T cells is a streamlined and highly regulated procedure involving T-cell-expansion and activation on a standardised platform. Here, the authors show that a personalized approach, taking the phenotypic attributes of individual pat
Externí odkaz:
https://doaj.org/article/f7959b99a7e04e99918762da2d538fbb
Publikováno v:
Rejuvenation Research.
Autor:
Kyle H. Vining, Anna E. Marneth, Kwasi Adu-Berchie, Joshua M. Grolman, Christina M. Tringides, Yutong Liu, Waihay J. Wong, Olga Pozdnyakova, Mariano Severgnini, Alexander Stafford, Georg N. Duda, F. Stephen Hodi, Ann Mullally, Kai W. Wucherpfennig, David J. Mooney
Publikováno v:
Nature Materials. 21:939-950
Autor:
Alexander J. Najibi, Ting-Yu Shih, David K. Y. Zhang, Junzhe Lou, Miguel C. Sobral, Hua Wang, Maxence O. Dellacherie, Kwasi Adu-Berchie, David J. Mooney
Publikováno v:
Cancer Immunology, Immunotherapy. 71:2957-2968
Autor:
Nahal Habibi, Tyler D. Brown, Kwasi Adu-Berchie, Stephanie Christau, Jeffery E. Raymond, David J. Mooney, Samir Mitragotri, Joerg Lahann
Publikováno v:
Langmuir. 38:5603-5616
Nanoparticle-based delivery of therapeutics to the brain has had limited clinical impact due to challenges crossing the blood-brain barrier (BBB). Certain cells, such as monocytes, possess the ability to migrate across the BBB, making them attractive
Autor:
Benjamin R. Freedman, Kwasi Adu‐Berchie, Carrie Barnum, George W. Fryhofer, Nabeel S. Salka, Snehal Shetye, Louis J. Soslowsky
Publikováno v:
Journal of Orthopaedic Research. 40:2308-2319
Operative treatment is assumed to provide superior outcomes to nonoperative (conservative) treatment following Achilles tendon rupture, however, this remains controversial. This study explores the effect of surgical repair on Achilles tendon healing.
Autor:
Yutong Liu, Kwasi Adu-Berchie, Joshua M. Brockman, Matthew Pezone, David K.Y. Zhang, Jingyi Zhou, Jason W. Pyrdol, Hua Wang, Kai W. Wucherpfennig, David J. Mooney
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 120(1)
Adoptive T cell transfer (ACT) therapies suffer from a number of limitations (e.g., poor control of solid tumors), and while combining ACT with cytokine therapy can enhance effectiveness, this also results in significant side effects. Here, we descri
Autor:
Kwasi Adu-Berchie, Joshua M. Brockman, Yutong Liu, David K.Y. Zhang, Alexander J. Najibi, Alexander Stafford, Miguel C. Sobral, Yoav Binenbaum, Maxence O. Dellacherie, David J. Mooney
Adoptive T cell therapy provides the T cell pool needed for immediate tumor debulking, but the infused T cells generally have a narrow repertoire for antigen recognition and limited ability for long-term protection. Here, we present a biomaterial pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37f3030095fe42b9ca7b7e66be395f89
https://doi.org/10.1101/2022.09.10.507437
https://doi.org/10.1101/2022.09.10.507437
Autor:
Gilles Berger, Erik H. Knelson, Jorge L. Jimenez-Macias, Michal O. Nowicki, Saemi Han, Eleni Panagioti, Patrick H. Lizotte, Kwasi Adu-Berchie, Alexander Stafford, Nikolaos Dimitrakakis, Lanlan Zhou, E. Antonio Chiocca, David J. Mooney, David A. Barbie, Sean E. Lawler
Immunotherapy has had a tremendous impact on cancer treatment in the past decade, with hitherto unseen responses at advanced and metastatic stages of the disease. However, the aggressive brain tumor glioblastoma (GBM) is highly immunosuppressive and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::663f56c8b95a09a68adec095017e5059
https://doi.org/10.1101/2022.02.28.481908
https://doi.org/10.1101/2022.02.28.481908